Premium
Aripiprazole found safe, tolerable, and effective in placebo‐controlled maintenance study
Publication year - 2017
Publication title -
the brown university child and adolescent psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7567
pISSN - 1527-8395
DOI - 10.1002/cpu.30239
Subject(s) - aripiprazole , placebo , psychopharmacology , psychiatry , medicine , schizophrenia (object oriented programming) , randomized controlled trial , psychology , psychotherapist , alternative medicine , pathology
Researchers conducted a double‐blind, placebo‐controlled, randomized trial of aripiprazole to study the medication's effectiveness as a maintenance medication. The point was to see if long‐term maintenance on the medication would be safe, tolerable, and effective for adolescents. The medication is already approved for treating teens 13 and older.